España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Inspira Technologies Oxy
IINNW
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.2500
0.01
4.17%
At close: -
$0.3500
0.1
40.00%
After Hours: Nov 25, 4:06 PM EDT
Get Report
Comment
Inspira Technologies Oxy (IINNW) Forecast
News
Earnings
Inspira Technologies Oxy (IINNW) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Inspira Technologies Oxy (NASDAQ:IINNW) Stock
Inspira Technologies Oxy Stock (NASDAQ: IINNW)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Inspira Receives Israeli Regulatory Approval ...
Benzinga Newsdesk
Tuesday, February 27, 2024
Inspira Nears First FDA 510(K) Approval, 3 US...
Benzinga Newsdesk
Thursday, February 08, 2024
Inspira Technologies Collaborates With A Lead...
Benzinga Newsdesk
Tuesday, January 09, 2024
Inspira Announces Plans To Launch And Target ...
Benzinga Newsdesk
Tuesday, January 02, 2024
Inspira Technologies Signs Letter Of Intent W...
Benzinga Newsdesk
Tuesday, December 26, 2023
Inspira Announces 95% Accuracy Results For HYLA Blood Sensor, Planning FDA Submission For Clearance In 2024
Happy Mohamed
Monday, November 06, 2023
Inspira Announces Israeli Innovation Authorit...
Benzinga Newsdesk
Thursday, May 11, 2023
Inspira Technologies Is Developing The VORTX Blood Oxygenator, A Unique Technology For Saturating Blood With Oxygen And Removing Carbon Dioxide
Happy Mohamed
Wednesday, March 22, 2023
Inspira Technologies Announces First In Human Of HYLA Blood Sensor In Clinical Study
Happy Mohamed
Thursday, November 10, 2022
Inspira Technologies Granted Patent By The Is...
Benzinga Newsdesk
Friday, January 28, 2022
Inspira Technologies Announces Has FDA Class I 510(k) Exempt component Of The ART System
Bill Haddad
Tuesday, October 26, 2021
EXCLUSIVE: Inspira Technologies Co-Founder & ...
Benzinga Newsdesk
EXCLUSIVE: Inspira Technologies Co-Founder & ...
Benzinga Newsdesk
EXCLUSIVE: Inspira Technologies Co-Founder & ...
Benzinga Newsdesk
EXCLUSIVE: Inspira Technologies Co-Founder & ...
Benzinga Newsdesk
Inspira Technologies Enters Europe; Signs Str...
Benzinga Newsdesk
Wednesday, September 29, 2021
From BZ's Small Cap Healthcare Conference: In...
Zoltan Suranyi
From BZ's Small Cap Healthcare Conference: In...
Zoltan Suranyi
From BZ's Small Cap Healthcare Conference: In...
Zoltan Suranyi
From BZ's Small Cap Healthcare Conference: In...
Zoltan Suranyi
From BZ's Small Cap Healthcare Conference: Inspira Technologies Co-Founder & CFO, Joe Hayon Begins Speaking
Zoltan Suranyi
Wednesday, September 22, 2021
Inspira Technologies Announces That The ART's Device 'brain' IS To Acquire An Algorithm Enhanced Digital Platform
Bill Haddad
Wednesday, September 15, 2021
Inspira Technologies Files Patent Application...
Benzinga Newsdesk